SDIC
ICPT

South Dakota Investment Council’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

South Dakota Investment Council’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,890
Closed -$159K – 632
2021
Q1 		$159K Hold
6,890
– – ﹤0.01% 598
2020
Q4 		$170K Hold
6,890
– – ﹤0.01% 582
2020
Q3 		$286K Hold
6,890
– – 0.01% 539
2020
Q2 		$330K Hold
6,890
– – 0.01% 516
2020
Q1 		$434K Hold
6,890
– – 0.01% 462
2019
Q4 		$854K Sell
6,890
-2,410
-26% -$216K 0.02% 439
2019
Q3 		$617K Hold
9,300
– – 0.01% 503
2019
Q2 		$740K Sell
9,300
-9,600
-51% -$859K 0.02% 465
2019
Q1 		$2.11M Hold
18,900
– – 0.04% 304
2018
Q4 		$1.91M Sell
18,900
-7,100
-27% -$736K 0.05% 287
2018
Q3 		$3.29M Sell
26,000
-2,600
-9% -$275K 0.07% 222
2018
Q2 		$2.4M Sell
28,600
-17,000
-37% -$1.24M 0.05% 280
2018
Q1 		$2.81M Hold
45,600
– – 0.06% 234
2017
Q4 		$2.66M Buy
45,600
+3,000
+7% +$189K 0.06% 255
2017
Q3 		$2.47M Hold
42,600
– – 0.05% 283
2017
Q2 		$5.16M Hold
42,600
– – 0.11% 162
2017
Q1 		$4.82M Sell
42,600
-1,800
-4% -$210K 0.1% 165
2016
Q4 		$4.82M Hold
44,400
– – 0.1% 161
2016
Q3 		$7.31M Hold
44,400
– – 0.15% 128
2016
Q2 		$6.33M Sell
44,400
-3,600
-8% -$525K 0.14% 134
2016
Q1 		$6.17M Buy
48,000
+11,800
+33% +$1.39M 0.13% 135
2015
Q4 		$5.41M Buy
36,200
+2,300
+7% +$389K 0.12% 141
2015
Q3 		$5.62M Buy
33,900
+1,700
+5% +$374K 0.13% 128
2015
Q2 		$7.77M Sell
32,200
-1,500
-4% -$399K 0.16% 112
2015
Q1 		$9.5M Sell
33,700
-5,800
-15% -$1.26M 0.18% 102
2014
Q4 		$6.16M Buy
+39,500
New +$7.3M 0.12% 129

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

South Dakota Investment Council's ICPT Position: Q2 2021 in Review

South Dakota Investment Council sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2021, closing a stake of 6,890 shares — an estimated $159K sold.

South Dakota Investment Council first reported a position in ICPT in Q4 2014 and held it in 26 quarters. The position peaked at $9.5M in Q1 2015. 129 funds tracked by Wall St. Rank hold ICPT as of Q2 2021.

  • South Dakota Investment Council reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • South Dakota Investment Council sold 6,890 Intercept Pharmaceuticals, Inc. shares in Q2 2021, an estimated $159K.
  • South Dakota Investment Council first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 26 quarters.
  • South Dakota Investment Council's Intercept Pharmaceuticals, Inc. position peaked at $9.5M in Q1 2015.
  • 129 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2021.

Based on South Dakota Investment Council's 13F filing for Q2 2021, filed 11 Aug 2021.